HIF1A and neoplasm: Interestingly, simvastatin, a statin with antioxidant properties, has been showed to reduce hypoxia-induced endothelium leakage and decrease ROS-induced HIF1α and VEGF expression, attenuating VEGF-derived tumor vessel hyperpermeability and improving cisplatin and cyclophosphamide efficacy [241].